Bishoy Morris

Bishoy Morris is an Associate Professor of Medicine at Weill Cornell Medical College, where he focuses on advancing precision oncology for urothelial and bladder cancers. His research bridges genomics, tumor biology, and clinical applications to improve patient outcomes.

• Education: M.B., B.Ch. from Assiut University College of Medicine (Egypt, 2004)

Research Interests encompass genomic heterogeneity, extrachromosomal DNA dynamics, immune checkpoint inhibitors, and circulating tumor DNA profiling. His work explores how mutagenic processes, such as APOBEC3 activity, drive cancer evolution and resistance.

Publication Trends highlight expertise in bladder cancer molecular subtypes, liquid biopsies, and computational tools for mutation analysis. Key themes include tumor-immune interactions, therapeutic vulnerabilities, and AI-driven clinical decision-making.

Grants & Funding include multiple NIH/NCI awards (2023–2028) for projects targeting APOBEC3A-induced instability and ecDNA in urothelial cancer. Additional support from the Department of Defense and Starr Cancer Consortium.

External Collaborations involve advisory roles at Bladder Cancer Advocacy Network and industry partnerships with Guardant Health. He contributes to professional platforms like UroToday.